Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,036.00
+1.10 (0.11%)
Sep 4, 2025, 3:30 PM IST
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 601.71 billion as of September 4, 2025. Its market cap has decreased by -32.40% in one year.
Market Cap
601.71B
Enterprise Value
601.92B
Revenue
320.25B
Ranking
n/a
PE Ratio
17.77
Stock Price
1,036.00
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 601.71B, an increase of 6,165.68%. That is a compound annual growth rate of 19.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 601.71B | -22.37% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | 539.83B | 101.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,787.83B |
| Divi's Laboratories | 1,636.35B |
| Cipla | 1,274.96B |
| Apollo Hospitals Enterprise | 1,112.32B |
| Mankind Pharma | 1,056.29B |
| Zydus Lifesciences | 1,014.49B |
| Fortis Healthcare | 722.19B |
| Alkem Laboratories | 627.30B |